Pricing & Access· May 22, 2026 · 15 min read
Topic
Market Access
Market access strategy, payer engagement, formulary positioning, and commercial launch planning for biopharma products.
Pricing & Access· May 22, 2026 · 12 min read
AMCP dossier evidence gaps that weaken payer review for a new specialty drug
By Ran Chen#AMCP Dossier#Formulary#Payer Review
Pipeline· May 22, 2026 · 13 min read
Compendia listing gaps for oncology access before label expansion
By Ran Chen#Oncology#Market Access#Medicare Part D
Pricing & Access· May 22, 2026 · 13 min read
Copay accumulator and maximizer monitoring for manufacturer support teams
Pricing & Access· May 22, 2026 · 17 min read
New-to-market payer blocks: the first 180 days after approval
Pricing & Access· May 22, 2026 · 12 min read
State Prescription Drug Affordability Boards: Launch-Risk Watchlist for Market Access Teams
By Ran Chen#Drug Pricing#Market Access#Payer Policy